Major non-ABO incompatibility caused by anti-Jk(a) in a patient before allogeneic hematopoietic stem cell transplantation.

M. Y. Kim, P. Chaudhary, I. A. Shulman, V. Pullarkat

Research output: Contribution to journalArticle

1 Scopus citations

Abstract

A 49-year-old white man with blood group AB, D+ was found to have alloanti-Jk(a) and -K when he developed a delayed hemolytic transfusion reaction before allogeneic hematopoietic stem cell transplant (HSCT). Given that his stem cell donor was blood group O, D+, Jk(a+), K-, rituximab was added to his conditioning regimen of fludarabine and melphalan to prevent hemolysis of engrafting Jk(a+) donor red blood cells. The patient proceeded to receive a peripheral blood stem cell transplant from a matched unrelated donor with no adverse events. To our knowledge, this is the first case of successful management of major non-ABO incompatibility caused by anti-Jk(a) in a patient receiving an allogeneic HSCT reported in the literature.

Original languageEnglish
Pages (from-to)11-14
Number of pages4
JournalUnknown Journal
Volume29
Issue number1
StatePublished - 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'Major non-ABO incompatibility caused by anti-Jk(a) in a patient before allogeneic hematopoietic stem cell transplantation.'. Together they form a unique fingerprint.

Cite this